Nephritic syndrome
Other namesAcute nephritic syndrome[1]
A graphic representation of the kidney.
SpecialtyNephrology Edit this on Wikidata
SymptomsOliguria[2]
CausesInfectious, autoimmune, or thrombotic[3]
Diagnostic methodUrinalysis, kidney biopsy[4]
TreatmentAntihypertensives[5]

Nephritic syndrome is a syndrome comprising signs of nephritis, which is kidney disease involving inflammation. It often occurs in the glomerulus, where it is called glomerulonephritis. Glomerulonephritis is characterized by inflammation and thinning of the glomerular basement membrane and the occurrence of small pores in the podocytes of the glomerulus. These pores become large enough to permit both proteins and red blood cells to pass into the urine (yielding proteinuria and hematuria, respectively). By contrast, nephrotic syndrome is characterized by proteinuria and a constellation of other symptoms that specifically do not include hematuria.[6] Nephritic syndrome, like nephrotic syndrome, may involve low level of albumin in the blood due to the protein albumin moving from the blood to the urine.[7]

Signs and symptoms

Hematuria (one of the symptoms of Nephritic syndrome

Historically, nephritic syndrome has been characterized by blood in the urine (hematuria), high blood pressure (hypertension), decreased urine output <400 ml/day (oliguria), red blood cell casts, pyuria, and mild to moderate proteinuria.[8][9] If the condition is allowed to progress without treatment, it can eventually lead to azotemia and uremic symptoms.[9] This constellation of symptoms contrasts with the classical presentation of nephrotic syndrome (excessive proteinuria >3.5 g/day, low plasma albumin levels (hypoalbuminemia) <3 g/L, generalized edema, and hyperlipidemia).[8][10]

Signs and symptoms that are consistent with nephritic syndrome include:

Causes

Purpura

Nephritic syndrome is caused by extensive inflammatory damage to the glomerulus capillaries, which is associated with a variety of medical conditions that we will discuss. Furthermore, the cause of this inflammation can be infectious, autoimmune, or thrombotic.[3] The causative conditions can be divided conveniently between age groups as follows, though it is important to note that many of the conditions listed in children/adolescents can also occur in adults with lower frequency, and vice versa:[4]

Children/adolescents

Adults

Pathophysiology

The pathophysiology of nephritic syndrome is dependent on the underlying disease process, which can vary depending on what condition the nephritic syndrome is secondary to. More specifically, different diseases (many of which are mentioned above in the Causes section) affect different segments of the glomerulus and cause disease-specific segments of the glomerulus to become inflamed. Most often, it is dependent on what part of the glomerulus is damaged by antibody-antigen complex (immune complex) deposition.[9] In all cases, however, the inflammatory processes in the glomerulus cause the capillaries to swell and the pores between podocytes become large enough that inappropriate contents in the blood plasma (i.e. red blood cells, protein, etc.) will begin to spill into the urine. This causes a decrease in glomerular filtration rate (GFR) and, if left untreated over time, will eventually produce uremic symptoms and retention of sodium and water in the body, leading to both edema and hypertension.[9]

Diagnosis

The diagnostic approach to nephritic syndrome includes evaluating the patient for any suspected underlying pathology that could cause a nephritic syndrome.

Physical examination

If the person in the office is being examined by a physician, some physical exam findings consistent with nephritic syndrome include the following:

Laboratory testing

If the physician is suspicious of a possible nephritic syndrome, then he/she may order some common lab tests including:

If nephritic syndrome is identified and diagnosed, then it is important for the physician to determine the underlying cause. To do this, he/she may order any of a large variety of relevant lab tests, some of which are included here:

Invasive testing

A kidney biopsy will provide a fully definitive diagnosis of nephritic syndrome and may also reveal the underlying cause of the nephritic syndrome depending on the underlying pathological process. On biopsy, a patient with nephritic syndrome would show inflammation of numerous glomeruli.[37]

Treatment

When a patient is confirmed to have nephritic syndrome, the main goal of treatment (regardless of the underlying cause) is to control elevated blood pressures and reduce active inflammation in the kidney itself.[4] Most often, the patient will need to be admitted to the hospital for close monitoring to ensure the efficacy of treatment and make adjustments as needed. Some treatment modalities commonly used to meet these goals include:

Once the acute phase of the nephritic syndrome is controlled, it is crucial to determine the underlying pathology that caused the onset of the acute nephritic syndrome and to treat that condition. If the underlying cause is not determined and treated appropriately, it increases the risk of a recurrence of nephritic syndrome or chronic kidney disease (CKD) in the future.[4]

Prognosis

Because nephritic syndrome is a syndrome and not a disease, the prognosis depends on the underlying cause. Generally, the prognosis of nephritic syndrome in children is better than it is in adults.[5]

Epidemiology

According to the CDC, nephritis/nephrosis/nephritic syndrome was the 9th leading cause of death in the United States in 2017.[45] It was listed as the cause of death for 50,633 out of the total 2,813,503 deaths reported in 2017.[45]

Geography

The southeast region of the United States reported a significantly higher death rate due to kidney disease than any other region in 2017. Mississippi reported the highest death rate due to kidney disease (21.7), followed by Louisiana (20.6) and Arkansas (19.7).[46] Although Vermont reported the lowest death rate due to kidney disease (3.3), the western United States reported the lowest regional average death rate due to kidney disease in 2017.[46]

Gender

Out of the 1,374,392 female deaths reported in the US in 2017, kidney disease was listed as the cause of death for 24,889 women and was reported as the 9th overall cause of death for women in 2017.[45]

Out of the 1,439,111 male deaths reported in the US in 2017, kidney disease was not listed in the top 10 causes of death.[45]

Race and ethnicity

Out of the 2,378,385 deaths reported in individuals who identified as White, kidney disease was ranked 10th overall (39,105 deaths) in causes of death in the US in 2017.[45]

Out of the 340,644 deaths reported in individuals who identified as Black or African American, kidney disease was ranked 8th overall (9,609 deaths) in causes of death in the US in 2017.[45]

Out of the 74,094 deaths reported in individuals who identified as Asian or Pacific Islander, kidney disease was ranked 9th overall (1,563 deaths) in causes of death in the US in 2017.[45]

Out of the 197,249 deaths reported in individuals who identified as Hispanic or Latino, kidney disease was ranked 10th overall (3,928 deaths) in causes of death in the US 2017.[45]

Other countries of world

In a review of Romanian cases, a 10-year review yielded that upon biopsy, nephritic syndrome was the second most common clinical syndrome at 21.9% (nephrotic syndrome was 52.3%)[47]

References

  1. "acute nephritic syndrome""at Dorland's Medical Dictionary
  2. 1 2 3 Madara, Bernadette; Pomarico-Denino, Vanessa (2008-07-08). Quick Look Nursing: Pathophysiology. Jones & Bartlett Learning. p. 484. ISBN 9780763749323.
  3. 1 2 Schrier, Robert W. (2008-10-01). Manual of Nephrology. Lippincott Williams & Wilkins. pp. 144–145. ISBN 9780781796194.
  4. 1 2 3 4 5 "Acute nephritic syndrome: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Retrieved 2015-10-27.
  5. 1 2 "Acute Nephritis; Nephrosis; Nephritic syndrome information. Patient | Patient". Patient. Retrieved 2015-10-27.
  6. Ferri, Fred F. (2017-05-25). Ferri's clinical advisor 2018 : 5 books in 1. Preceded by: Ferri, Fred F. Philadelphia, PA. p. 889. ISBN 978-0-323-52957-0. OCLC 989151714.{{cite book}}: CS1 maint: location missing publisher (link)
  7. 1 2 Schrier, Robert W. (2010). Renal and Electrolyte Disorders. Lippincott Williams & Wilkins. pp. 559–560. ISBN 978-1-60831-072-2.
  8. 1 2 Kibble, Jonathan David (2009). Medical physiology : the big picture. Halsey, Colby Ray. New York: McGraw-Hill. p. 221. ISBN 978-0-07-164302-3. OCLC 469141953.
  9. 1 2 3 4 5 6 7 8 9 10 Harrison's principles of internal medicine. Longo, Dan L. (Dan Louis), 1949-, Fauci, Anthony S., 1940-, Kasper, Dennis L., Hauser, Stephen L., Jameson, J. Larry., Loscalzo, Joseph. (18th ed.). New York: McGraw-Hill. 2012. pp. 2334–2345. ISBN 978-0-07-174890-2. OCLC 747712285.{{cite book}}: CS1 maint: others (link)
  10. Floege, Jürgen; Johnson, Richard J.; Feehally, John (2010). Comprehensive Clinical Nephrology (Fourth ed.). Mosby. p. 198. doi:10.1016/B978-0-323-05876-6.00015-0. ISBN 9780323058766.
  11. Schrier, Robert W. (2010-01-01). Renal and Electrolyte Disorders. Lippincott Williams & Wilkins. p. 560. ISBN 9781608310722.
  12. Floege, Jurgen; Johnson, Richard J.; Feehally, John (2010-11-08). Comprehensive Clinical Nephrology E-Book. Elsevier Health Sciences. pp. 202–203. ISBN 978-0-323-08133-7.
  13. Krueger, Gerhard R. F.; Buja, L. Maximilian (2013-03-12). Atlas of Anatomic Pathology with Imaging: A Correlative Diagnostic Companion. Springer Science & Business Media. p. 287. ISBN 9781447128465.
  14. Whelton, Paul K.; Carey, Robert M.; Aronow, Wilbert S.; Casey, Donald E.; Collins, Karen J.; Dennison Himmelfarb, Cheryl; DePalma, Sondra M.; Gidding, Samuel; Jamerson, Kenneth A.; Jones, Daniel W.; MacLaughlin, Eric J. (June 2018). "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Hypertension. 71 (6): e13–e115. doi:10.1161/HYP.0000000000000065. ISSN 1524-4563. PMID 29133356.
  15. 1 2 "Subtopic 3: Microscopic Examination of Urine Sediment". Texas Collaborative. November 19, 2004. Archived from the original on 2004-11-19. Retrieved January 22, 2020.
  16. Davin, J. C.; Ten Berge, I. J.; Weening, J. J. (March 2001). "What is the difference between IgA nephropathy and Henoch–Schönlein purpura nephritis?". Kidney International. 59 (3): 823–834. doi:10.1046/j.1523-1755.2001.059003823.x. ISSN 0085-2538. PMID 11231337.
  17. "Acute Poststreptococcal Glomerulonephritis: Background, Pathophysiology, Epidemiology". 2018-12-05. {{cite journal}}: Cite journal requires |journal= (help)
  18. Comprehensive pediatric nephrology. Geary, Denis F., Schaefer, Franz. Philadelphia, PA: Mosby/Elsevier. 2008. pp. 309–317. ISBN 978-0-323-07096-6. OCLC 324995599.{{cite book}}: CS1 maint: others (link)
  19. Kraft, D. M.; Mckee, D.; Scott, C. (August 1998). "Henoch–Schönlein purpura: a review". American Family Physician. 58 (2): 405–408, 411. ISSN 0002-838X. PMID 9713395.
  20. Cody, Ellen M.; Dixon, Bradley P. (February 2019). "Hemolytic Uremic Syndrome". Pediatric Clinics of North America. 66 (1): 235–246. doi:10.1016/j.pcl.2018.09.011. ISSN 1557-8240. PMID 30454746. S2CID 53875876.
  21. Salama, A. D.; Levy, J. B.; Lightstone, L.; Pusey, C. D. (2001-09-15). "Goodpasture's disease". Lancet. 358 (9285): 917–920. doi:10.1016/S0140-6736(01)06077-9. ISSN 0140-6736. PMID 11567730. S2CID 40175400.
  22. Ward, M. M. (2000-11-13). "Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995". Archives of Internal Medicine. 160 (20): 3136–3140. doi:10.1001/archinte.160.20.3136. ISSN 0003-9926. PMID 11074743.
  23. Lohr, James W. (January 10, 2018). "Rapidly Progressive Glomerulonephritis". Medscape. Retrieved January 21, 2020.
  24. Bhowmik, Dipankar (January 2011). "Clinical Approach to Rapidly Progressive Renal Failure" (PDF). Journal of the Association of Physicians of India. 59: 38–44. PMID 21751663.
  25. Robbins basic pathology. Kumar, Vinay, 1944-, Robbins, Stanley L. (Stanley Leonard), 1915-2003. (8th ed.). Philadelphia, PA: Saunders/Elsevier. 2007. pp. 406–408. ISBN 978-1-4160-2973-1. OCLC 69672074.{{cite book}}: CS1 maint: others (link)
  26. Retamozo, Soledad; Brito-Zerón, Pilar; Bosch, Xavier; Stone, John H.; Ramos-Casals, Manuel (November 2013). "Cryoglobulinemic disease". Oncology (Williston Park, N.Y.). 27 (11): 1098–1105, 1110–1116. ISSN 0890-9091. PMID 24575538.
  27. Habib, R.; Gubler, M. C.; Loirat, C.; Mäiz, H. B.; Levy, M. (April 1975). "Dense deposit disease: a variant of membranoproliferative glomerulonephritis". Kidney International. 7 (4): 204–215. doi:10.1038/ki.1975.32. ISSN 0085-2538. PMID 1095806.
  28. "Tips for having your blood pressure taken". National Heart, Lung, and Blood Institute. July 2, 2014. Archived from the original on July 2, 2014.
  29. "Techniques: Heart Sounds & Murmurs". University of Washington Department of Medicine. Retrieved January 22, 2020.
  30. "Electrolytes". MedlinePlus. November 20, 2017. Retrieved January 22, 2020.
  31. "Creatinine Blood Test". MedlinePlus. July 15, 2017. Retrieved January 22, 2020.
  32. "BUN - blood test". MedlinePlus. April 29, 2019. Retrieved January 22, 2020.
  33. "Urinalysis". MedlinePlus. February 7, 2019. Retrieved January 22, 2020.
  34. Lee, Andrew; Mirrett, Stanley; Reller, L. Barth; Weinstein, Melvin P. (November 2007). "Detection of bloodstream infections in adults: how many blood cultures are needed?". Journal of Clinical Microbiology. 45 (11): 3546–3548. doi:10.1128/JCM.01555-07. ISSN 0095-1137. PMC 2168497. PMID 17881544.
  35. Kavanaugh, A.; Tomar, R.; Reveille, J.; Solomon, D. H.; Homburger, H. A. (January 2000). "Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens". Archives of Pathology & Laboratory Medicine. 124 (1): 71–81. doi:10.5858/2000-124-0071-GFCUOT. ISSN 0003-9985. PMID 10629135.
  36. Bradwell, A. R. (1999). Advanced atlas of autoantibody patterns. Mead, G. P., Stokes, R. P., Binding Site Limited. Birmingham: The Binding Site. ISBN 0-7044-8510-9. OCLC 41258931.
  37. "Acute nephritic syndrome". MedlinePlus. July 16, 2019. Retrieved January 22, 2020.
  38. Allen, C.; Glasziou, P.; Del Mar, C. (1999-10-09). "Bed rest: a potentially harmful treatment needing more careful evaluation". Lancet. 354 (9186): 1229–1233. doi:10.1016/s0140-6736(98)10063-6. ISSN 0140-6736. PMID 10520630. S2CID 12196831.
  39. "Fluid Restricted Diet". Intermountain Healthcare. 2016. Retrieved January 23, 2020.
  40. Mahtani, Kamal R.; Heneghan, Carl; Onakpoya, Igho; Tierney, Stephanie; Aronson, Jeffrey K.; Roberts, Nia; Hobbs, F. D. Richard; Nunan, David (December 1, 2018). "Reduced Salt Intake for Heart Failure: A Systematic Review". JAMA Internal Medicine. 178 (12): 1693–1700. doi:10.1001/jamainternmed.2018.4673. ISSN 2168-6114. PMC 6422065. PMID 30398532. S2CID 53241717.
  41. Ali, Syed Salman; Sharma, Pramod Kumar; Garg, Vipin Kumar; Singh, Avnesh Kumar; Mondal, Sambhu Charan (April 2012). "The target-specific transporter and current status of diuretics as antihypertensive". Fundamental & Clinical Pharmacology. 26 (2): 175–179. doi:10.1111/j.1472-8206.2011.01012.x. ISSN 1472-8206. PMID 22145583. S2CID 43171023.
  42. Wright, Jackson T.; Bakris, George; Greene, Tom; Agodoa, Larry Y.; Appel, Lawrence J.; Charleston, Jeanne; Cheek, DeAnna; Douglas-Baltimore, Janice G.; Gassman, Jennifer; Glassock, Richard; Hebert, Lee (2002-11-20). "Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial". JAMA. 288 (19): 2421–2431. doi:10.1001/jama.288.19.2421. ISSN 0098-7484. PMID 12435255.
  43. Rhen, Turk; Cidlowski, John A. (2005-10-20). "Antiinflammatory action of glucocorticoids--new mechanisms for old drugs". The New England Journal of Medicine. 353 (16): 1711–1723. doi:10.1056/NEJMra050541. ISSN 1533-4406. PMID 16236742. S2CID 5744727.
  44. Tattersall, James; Dekker, Friedo; Heimbürger, Olof; Jager, Kitty J.; Lameire, Norbert; Lindley, Elizabeth; Van Biesen, Wim; Vanholder, Raymond; Zoccali, Carmine; ERBP Advisory Board (July 2011). "When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study". Nephrology, Dialysis, Transplantation. 26 (7): 2082–2086. doi:10.1093/ndt/gfr168. ISSN 1460-2385. PMID 21551086.
  45. 1 2 3 4 5 6 7 8 "Leading causes of death and numbers of deaths, by sex, race, and Hispanic origin: United States, 1980 and 2017" (PDF). CDC. 2018. Retrieved January 21, 2020.
  46. 1 2 "Kidney Disease Mortality by State". CDC. 2017. Retrieved January 21, 2020.
  47. Covic, Adrian; Schiller, Adalbert; Volovat, Carmen; Gluhovschi, Gheorghe; Gusbeth-Tatomir, Paul; Petrica, Ligia; Caruntu, Irina-Draga; Bozdog, Gheorghe; Velciov, Silvia; Trandafirescu, Virginia; Bob, Flaviu; Gluhovschi, Cristina (1 February 2006). "Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases". Nephrology Dialysis Transplantation. 21 (2): 419–424. doi:10.1093/ndt/gfi207. ISSN 0931-0509. PMID 16249204. Retrieved 1 May 2020.

Further reading

  • Crutchlow, Eileen M.; Dudac, Pamela J.; MacAvoy, Suzanne; Madara, Bernadette R. (2002-01-01). Pathophysiology. Jones & Bartlett Learning. ISBN 9781556425653.
  • Schrier, Robert W. (2014-05-13). Manual of Nephrology. Lippincott Williams & Wilkins. ISBN 9781469887364.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.